Clinical Trial Update: A Phase IIa Repeat Dose AXP1275 vs Placebo Cross-over Trial With Pulmonary Allergen Challenge in Adults With Asthma [Phase 2]

View source ↗

Summary

This document reports completion of a Phase IIa cross-over trial evaluating AXP1275 versus placebo in adults with asthma undergoing a pulmonary allergen challen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• AXP1275

Snippet

Sponsor: Axikin Pharmaceuticals, Inc. | Conditions: Atopic Asthma | Phase 2 | Status: COMPLETED